Aroa Biosurgery Ltd (ARX) — Capital Reinvestment Ratio

Latest as of September 2025: 0.12x

Aroa Biosurgery Ltd (ARX) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (AU$3.64 Million) in capital expenditures (AU$455.08K). Check tangible net worth ratio of Aroa Biosurgery Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

AU$3.64 Million
AUD

Capital Expenditures

AU$455.08K
AUD

Data as of

Sep 2025
Most recent filing

Aroa Biosurgery Ltd Capital Reinvestment Ratio (2020–2020)

This chart tracks Aroa Biosurgery Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Aroa Biosurgery Ltd.

Annual Capital Reinvestment Ratio for Aroa Biosurgery Ltd (2020–2020)

Year-by-year Capital Reinvestment Ratio for Aroa Biosurgery Ltd from 2020 to 2020. See ARX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2020 1.13x AU$1.58 Million AU$1.78 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow